| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 887 |
| 1 | PREDNISONE | 770 |
| 2 | ADALIMUMAB | 694 |
| 3 | INFLIXIMAB-DYYB | 636 |
| 4 | VEDOLIZUMAB | 585 |
| 5 | METHOTREXATE SODIUM | 501 |
| 6 | METHOTREXATE | 445 |
| 7 | MESALAMINE | 406 |
| 8 | AZATHIOPRINE | 400 |
| 9 | ADALIMUMAB-ADAZ | 325 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAMPHOR, EUCALYPTUS OIL AND MENTHOL | 1 | 0.5000 |
| 1 | INFLIXIMAB-DYYB | 636 | 0.1846 |
| 2 | ALOGLIPTIN AND METFORMIN HYDROCHLORIDE | 4 | 0.0286 |
| 3 | THROMBIN HUMAN AND FIBRINOGEN | 6 | 0.0179 |
| 4 | ADALIMUMAB-AFZB | 42 | 0.0157 |
| 5 | MESALAMINE | 406 | 0.0144 |
| 6 | MIRIKIZUMAB-MRKZ | 11 | 0.0122 |
| 7 | ADALIMUMAB-RYVK | 13 | 0.0119 |
| 8 | FERRIC DERISOMALTOSE | 13 | 0.0095 |
| 9 | ETRASIMOD | 13 | 0.0077 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 1741 |
| 1 | Corticosteroid [EPC] | 1080 |
| 2 | Integrin Receptor Antagonist [EPC] | 585 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 445 |
| 4 | Aminosalicylate [EPC] | 432 |
| 5 | Purine Antimetabolite [EPC] | 400 |
| 6 | Interleukin-23 Antagonist [EPC] | 365 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 270 |
| 8 | Interleukin-12 Antagonist [EPC] | 230 |
| 9 | Janus Kinase Inhibitor [EPC] | 186 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 6 | 0.0073 |
| 1 | Integrin Receptor Antagonist [EPC] | 585 | 0.0067 |
| 2 | Provitamin D2 Compound [EPC] | 170 | 0.0057 |
| 3 | Bile Acid Sequestrant [EPC] | 55 | 0.0045 |
| 4 | Aminosalicylate [EPC] | 432 | 0.0043 |
| 5 | Purine Antimetabolite [EPC] | 400 | 0.0040 |
| 6 | Interleukin-23 Antagonist [EPC] | 365 | 0.0035 |
| 7 | Macrolide Antibacterial [EPC] | 3 | 0.0030 |
| 8 | Interleukin-12 Antagonist [EPC] | 230 | 0.0022 |
| 9 | Somatostatin Analog [EPC] | 14 | 0.0020 |